MedPath
FDA Approval

Vitranol Fe

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
PureTek Corporation
DUNS: 785961046
Effective Date
January 11, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Chromium nicotinate(35 ug in 1 1)
Vitamin A acetate(1500 ug in 1 1)
Folic acid(1000 ug in 1 1)
Riboflavin(3.4 mg in 1 1)
Nicotinamide(20 mg in 1 1)
Vitamin B12(8 ug in 1 1)
Vitamin C(120 mg in 1 1)
Calcium carbonate(200 mg in 1 1)
Pyridoxine(20 mg in 1 1)
Thiamine(3 mg in 1 1)
Magnesium oxide(200 mg in 1 1)
Zinc oxide(25 mg in 1 1)
Manganese sulfate(2.3 mg in 1 1)
Ferrous fumarate(27 mg in 1 1)
Molybdenum(45 ug in 1 1)
Vitamin D3(20 ug in 1 1)
Selenious acid(55 ug in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Vitranol Fe

Product Details

NDC Product Code
59088-173
Route of Administration
ORAL
Effective Date
January 11, 2023
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
COCOAInactive
Code: D9108TZ9KGClass: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
Code: A150AY412VClass: ACTIBQuantity: 35 ug in 1 1
Code: 3LE3D9D6OYClass: ACTIMQuantity: 1500 ug in 1 1
Code: 935E97BOY8Class: ACTIBQuantity: 1000 ug in 1 1
Code: TLM2976OFRClass: ACTIBQuantity: 3.4 mg in 1 1
Code: 25X51I8RD4Class: ACTIBQuantity: 20 mg in 1 1
Code: P6YC3EG204Class: ACTIBQuantity: 8 ug in 1 1
Vitamin CActive
Code: PQ6CK8PD0RClass: ACTIBQuantity: 120 mg in 1 1
Code: H0G9379FGKClass: ACTIMQuantity: 200 mg in 1 1
Code: 68Y4CF58BVClass: ACTIMQuantity: 20 mg in 1 1
ThiamineActive
Code: 8K0I04919XClass: ACTIRQuantity: 3 mg in 1 1
Code: 3A3U0GI71GClass: ACTIBQuantity: 200 mg in 1 1
Code: SOI2LOH54ZClass: ACTIMQuantity: 25 mg in 1 1
Code: W00LYS4T26Class: ACTIMQuantity: 2.3 mg in 1 1
Code: R5L488RY0QClass: ACTIMQuantity: 27 mg in 1 1
Code: 81AH48963UClass: ACTIBQuantity: 45 ug in 1 1
Code: 1C6V77QF41Class: ACTIBQuantity: 20 ug in 1 1
Code: H6241UJ22BClass: ACTIBQuantity: 55 ug in 1 1
Code: WR1WPI7EW8Class: ACTIMQuantity: 30 mg in 1 1

Drug Labeling Information

Complete FDA-approved labeling information including indications, dosage, warnings, contraindications, and other essential prescribing details.

WARNINGS SECTION

WARNING:

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Administration of folic acid alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B 12 is deficient.

Precaution Section

Folic acid in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive.

There is a potential danger in administering folic acid to patients with undiagnosed anemia, since folic acid may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress. This may result in severe nervous system damage before the correct diagnosis is made. Adequate doses of vitamin B 12 may prevent, halt, or improve the neurologic changes caused by pernicious anemia.

The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.

For use on the order of a healthcare practitioner.
Call your doctor about side effects. To report side effects, callPureTek Corporation at
1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Drug Interactions:

Vitranol FE is not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, or Clopidogrel).

Adverse Reactions:

Folic Acid: Allergic sensitizations have been reported following both oral and parenteral administration of folic acid.

Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) occur occasionally, but are usually mild and may subside with continuation of therapy. Although the absorption of iron is best when taken between meals, giving Vitranol FE after meals may control occasional gastrointestinal disturbances. Vitranol FE is best absorbed when taken at
bedtime.

Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.


OVERDOSAGE SECTION

OVERDOSE:

Iron: Signs and Symptoms: Iron is toxic. Acute overdosage of iron may cause nausea and vomiting and, in severe cases, cardiovascular collapse and death. Other symptoms include pallor and cyanosis, melena, shock, drowsiness, and coma. The estimated overdose of orally ingested iron is 300 mg/kg body weight. When overdoses are ingested by children, severe
reactions, including fatalities, have resulted.Vitranol FE should be stored beyond the reach of children to prevent against accidental iron poisoning.Keep this and all other drugs out of reach of children.

Treatment:

For specific therapy, exchange transfusion and chelating agents should be used. For general management, perform gastric lavage with sodium bicarbonate solution or milk. Administer intravenous fluids and electrolytes and use oxygen.


© Copyright 2025. All Rights Reserved by MedPath